Metabolic Syndrome, Blood and Chinese Medicine – Sharon Weizenbaum

Generated with Avocode.Group 238Path 825Path 826Path 827Path 828Path 829Path 830Path 831Path 832Path 833Path 834Path 835Path 836Path 837Path 838Path 839Path 840Path 841Path 842Path 843Path 844Path 845Path 846Path 847Path 848Path 849Path 850Path 851Path 852Path 853Path 854Path 855Path 856Path 857Path 858Path 859Path 860Path 861Path 862Path 863Path 864Path 865Path 866Path 867Path 868Path 869Path 870Path 871Path 872Path 873Path 874Path 875Path 876Path 877Path 878Path 879Path 880Path 881Path 882Path 883Path 884Path 885Path 886Path 887Path 888Path 889Path 890Path 891Path 892Path 893Path 894Path 895Path 896Path 897

Lecture from ICCM#2016

Metabolic Syndrome is associated with obesity, diabetes, hyperlipidemia, hypertension and cardiovascular illness and insulin resistance.  In western cultures it is on the rise and in our Chinese medical clinics, it is something we see every day.

How do with think about this from a Chinese medical perspective?  Are there common diagnostic trends we can recognize in these patients?

Using her “clarifying diagnosis” methods, Sharon Weizenbaum has observed that the diagnosis for most of these patients includes blood pathology.  In this half-day course, Sharon will explain exactly what she sees in these patients that led her to this conclusion.  She will also explain the concept and diagnosis of systemic, rather than local, blood stasis in which the blood, in general, becomes too viscous.  Then she will offer the patho-mechanisms from which this viscous blood leads to obesity, hypertension and hyperlipidemia. Of course, the proof is in the pudding so she will then share the Chinese medical blood treatments that have given the results of lower blood pressure, blood insulin levels and blood cholesterol.

עשית כבר לייק לעמוד הפייסבוק שלנו?

Leave a Reply

Your email address will not be published. Required fields are marked *

סדנא עם Dr. Yu Guo Jun בישראל ​

שלושה ימים של צמחי מרפא סיניים